Susheel K. Kodali, MD

Board Certifications: 
Cardiovascular Disease, Interventional Cardiology, Interventional Cardiology, Cardiovascular Disease
Accepting New Patients
Profile Headshot

Overview

Susheel K. Kodali, MD is the co-director of the Structural Heart & Valve Center at NewYork-Presbyterian/ Columbia University Medical Center. Dr. Kodali is also the director of the interventional cardiology fellowship program and an assistant professor in medicine at CUMC.

Board-certified in interventional cardiology, endovascular medicine, and cardiovascular disease, Dr. Kodali specializes in the percutaneous treatment of coronary artery and structural heart disease, and cardiac catheterization.

Dr. Kodali was named New York Metro Area’s Top Doctor in 2012 and 2015 by Castle Connolly's Top Doctors™ and New York Magazine’s Top Doctors in 2012 and 2015. Dr. Kodali serves as the institutional co-investigator of the PARTNER trials and associated registries and is a member of the PARTNER trial steering committee.

Dr. Kodali attended medical school at The University of California, Los Angeles. He did his residency and a fellowship program in clinical cardiology at the University of California, San Francisco, and a fellowship program in interventional cardiology at Columbia University Irving Medical Center.

Areas of Expertise / Conditions Treated

  • Angioplasty, Percutaneous Transluminal
  • Heart Valve Disease
  • Interventional Cardiology
  • TAVR (Transcatheter Aortic Valve Replacement)
  • Transcatheter Aortic Valve (TAVR)

Academic Appointments

  • Associate Professor of Medicine at CUMC

Administrative Titles

  • Director, Structural Heart & Valve Center

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center
  • NewYork-Presbyterian Lawrence Hospital

Gender

  • Male

Schedule an Appointment

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Location(s)

CUMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032
Primary

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NYP Employee Plan
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care

AgeWell

  • Medicare Managed Care
  • Special Needs Plan

Amida Care

  • Special Needs Plan

Capital District Physician Health Plan

  • Capital District Physician Health Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Elderplan

  • Medicare Managed Care

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • EPO
  • Medicare Managed Care
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs Plan

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • University of California Los Angeles School of Medicine
  • 1998 University of California
  • Residency: University of California-San Francisco Medical Center
  • Residency: 2001 University Of California At San Francisco
  • Fellowship: University of California-San Francisco Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Fellowship: 2004 University Of California At San Francisco

Board Certifications

  • Cardiovascular Disease
  • Interventional Cardiology
  • Interventional Cardiology
  • Cardiovascular Disease
America's Top Doctor
NY Top Doctor

Research

Grants

EARLY FEASIBILITY STUDY OF THE CARDIOVALVE SYSTEM FOR TRICUSPID REGURGITATION (CARDIOVALVE) (P&S Industry Clinical Trial)

Jun 29 2020 - Jun 29 2025

EARLY FEASIBILITY STUDY OF THE EDWARDS EVOQUE TRICUSPID VALVE REPLACEMENT SYSTEM (P&S Industry Clinical Trial)

Jun 15 2020 - Jun 15 2025

EDWARDSPASCAL TRANSCATHETER VALVE REPAIR SYSTEM PIVOTAL CLINICAL TRIAL (CLASP II TR): A PROSPECTIVE, MULTICENTER, RANDOMIZED, CONTROLLED PIVOTAL TRIAL TO EVALUATE THE SAFETY AND EFFECTIVENESS OF TRANSCATHETER TRICUSPID VALVE REPAIR WITH THE EDWARDS (P&S Industry Clinical Trial)

May 20 2020 - May 20 2025

EVALUATIONOF THE SAFETY AND PERFORMANCE OF MEDTRONIC INTREPID? TRANSCATHETER MITRAL VALVE REPLACEMENT SYSTEM WITH TRANSFEMORAL TRANSSEPTAL ACCESS IN PATIENTS WITH SEVERE, SYMPTOMATIC MITRAL REGURGITATION (P&S Industry Clinical Trial)

Mar 20 2020 - Mar 20 2025

ASSESSMENT OF THE CARILLON? MITRAL CONTOUR SYSTEM? IN TREATING FUNCTIONAL MITRAL REGURGITATION ASSOCIATED WITH HEART FAILURE THE CARILLON TRIAL (P&S Industry Clinical Trial)

Feb 5 2020 - Feb 5 2025

EVALUATION OF THE PORTICO? NG TRANSCATHETER AORTIC VALVE IN HIGH AND EXTREME RISK PATIENTS WITH SYMPTOMATIC SEVERE AORTIC STENOSIS (P&S Industry Clinical Trial)

Jan 16 2020 - Jan 16 2025

EARLY FEASIBILITY STUDY OF THE ACCUCINCH? VENTRICULAR REPAIR SYSTEM IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION (HFREF) (P&S Industry Clinical Trial)

Nov 27 2018 - Nov 27 2024

CLINICAL TRIAL TO EVALUATE CARDIOVASCULAR OUTCOMES IN PATIENTS TREATED WITH THE TRICUSPID VALVE REPAIR SYSTEM PIVOTAL (TRILUMINATE PIVOTAL) (P&S Industry Clinical Trial)

Nov 26 2019 - Nov 26 2024

REPRISE IV: REPOSITIONABLE PERCUTANEOUS REPLACEMENT OF STENOTIC AORTIC VALVE THROUGH IMPLANTATION OF LOTUS EDGE VALVE SYSTEM IN INTERMEDIATE SURGICAL RISK SUBJECTS (P&S Industry Clinical Trial)

Apr 16 2019 - Apr 16 2024

EDWARDS PASCAL TRANSCATHETER VALVE REPAIR SYSTEM IN TRICUSPID REGURGITATION (CLASP TR) EARLY FEASIBILITY STUDY (P&S Industry Clinical Trial)

Mar 20 2019 - Mar 20 2024

EDWARDSPASCAL TRANSCATHETER MITRAL VALVE REPAIR SYSTEM PIVOTAL CLINICAL TRIAL (CLASP IID): A PROSPECTIVE, MULTICENTER, RANDOMIZED, CONTROLLED PIVOTAL TRIAL TO EVALUATE THE SAFETY AND EFFECTIVENESS OF TRANSCATHETER MITRAL VALVE REPAIR (P&S Industry Clinical Trial)

Jan 29 2019 - Jan 29 2024

EARLY FEASIBILITY STUDY OF THE PERCUTANEOUS 4TECH TRICINCH COIL TRICUSPID VALVE REPAIR SYSTEM (P&S Industry Clinical Trial)

Dec 18 2018 - Dec 18 2023

PARTNER3 TRIAL MITRAL VALVE IN VALVE A PROSPECTIVE, SINGLE-ARM, MULTICENTER STUDY TO INVESTIGATE THE SAFETY AND EFFECTIVENESS OF SAPIEN 3 TRANSCATHETER HEART VALVE IMPLANTATION IN PATIENTS WITH A FAILING MITRAL BIOPROSTHETIC VALVE (P&S Industry Clinical Trial)

Dec 3 2018 - Dec 3 2023

17-518:THE MITRACLIP? EXPAND STUDY A CONTEMPORARY, PROSPECTIVE STUDY EVALUATING REAL-WORLD EXPERIENCE OF PERFORMANCE AND SAFETY FOR THE NEXT GENERATION OF MITRACLIP? DEVICES (P&S Industry Clinical Trial)

Sep 21 2018 - Sep 21 2023

APROSPECTIVE, SINGLE-ARM, CONTROLLED, MULTICENTER STUDY TO ESTABLISH THE SAFETY AND EFFECTIVENESS OF THE CENTERA THV SYSTEM IN INTERMEDIATE RISK PATIENTS WHO HAVE SYMPTOMATIC, SEVERE, CALCIFIC, AORTIC STENOSIS REQUIREING AORTIC VALVE REPLACEMENT (P&S Industry Clinical Trial)

Sep 5 2018 - Sep 5 2023

EDWARDS CARDIOBANDTM TRICUSPID VALVE RECONSTRUCTION SYSTEM EARLY FEASIBILITY STUDY (P&S Industry Clinical Trial)

Jul 25 2018 - Jul 25 2023

TRANSCATHETER MITRAL VALVE REPLACEMENT WITH THE MEDTRONIC INTREPID TMVR SYSTEM IN PATIENTS WITH SEVERE SYMPTOMATIC MITRAL REGURGITATION APOLLO TRIAL (P&S Industry Clinical Trial)

Jan 12 2018 - Jan 12 2023

COAPT CONTINUED ACCESS STUDY (CAS) (P&S Industry Clinical Trial)

Dec 15 2017 - Dec 15 2022

EVALUATION OF TRANSCATHETER AORTIC VALVE REPLACEMENT COMPARED TO SURVEILLANCE FOR PATIENTS WITH ASYMPTOMATIC SEVERE AORTIC STENOSIS: EARLY TAVR TRIAL (P&S Industry Clinical Trial)

Mar 29 2017 - Mar 29 2022

PIVOTAL CLINICAL STUDY TO EVALUATE THE SAFETY AND EFFECTIVENESS OF MANTA VASCULAR CLOSURE DEVICE (P&S Industry Clinical Trial)

Feb 27 2017 - Feb 27 2022

THE REFLECT TRIAL A RANDOMIZED EVALUATION OF THE TRIGUARD? HDH EMBOLIC DEFLECTION DEVICE TO REDUCE THE IMPACT OF CEREBRAL EMBOLIC LESIONS AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION (P&S Industry Clinical Trial)

Oct 6 2016 - Oct 6 2021

EVALUATIONOF THE SAFETY AND PERFORMANCE OF THE TWELVE INTREPID? TRANSCATHETER MITRAL VALVE REPLACEMENT SYSTEM IN HIGH RISK PATIENTS WITH SEVERE, SYMPTOMATIC MITRAL REGURGITATION -THE TWELVE INTREPID? TMVR PILOT STUDY (P&S Industry Clinical Trial)

Sep 30 2016 - Sep 23 2021

INTERVENTIONAL CARDIOLOGY FELLOWSHIP (Private)

Jul 1 2020 - Jun 30 2021

STRUCTURAL HEART FELLOWSHIP PROGRAM (Private)

Jul 1 2020 - Jun 30 2021

TRANSCATHER AORTIC VALVE REPLACEMENT TO UNLOAD THE LEFT VENTRICLE IN PATIENTS WITH ADVANCED HEARTS FAILURE: A RANDOMIZED TRIAL (TAVR UNLOAD) (Private)

May 26 2016 - May 25 2021

THE MITRAL TRIAL - MITRAL IMPLANTATION OF TRANSCATHETER VALVES IN NATIVE MITRAL STENOSIS (P&S Industry Clinical Trial)

Sep 30 2015 - Sep 30 2020

2019 STRUCTURAL HEART FELLOWSHIP PROGRAM (Private)

Jul 1 2019 - Jun 30 2020

2019 STRUCTURAL HEART FELLOWSHIP PROGRAM (Private)

Jul 1 2019 - Jun 30 2020

2019 STRUCTURAL HEART FELLOWSHIP PROGRAM (Private)

Jul 1 2019 - Jun 30 2020

2019 STRUCTURAL HEART FELLOWSHIP PROGRAM (Private)

Jul 1 2019 - Jun 30 2020

2019 STRUCTURAL HEART FELLOWSHIP PROGRAM (Private)

Jul 1 2019 - Jun 30 2020

PROTECT TAVR: STROKE PROTECTION WITH SENTINEL DURING TRANSCATHETER AORTIC VALVE REPLACEMENT CLINICAL STUDY (P&S Industry Clinical Trial)

Jun 1 2020 - Jan 6 2020

THE MEDTRONIC COREVALVE? EVOLUT? R US CLINICAL STUDY (P&S Industry Clinical Trial)

Dec 12 2014 - Dec 12 2019

REPRISE III: REPOSITIONABLE PERCUTANEOUS REPLACEMENT OF STENOTIC AORTIC VALVE THROUGH IMPLANTATION OF LOTUS - VALVE SYSTEM - RANDOMIZED CLINICAL EVALUATION (P&S Industry Clinical Trial)

Nov 11 2014 - Nov 11 2019

CEREBRAL PROTECTION IN TRANSCATHETER AORTIC VALVE REPLACEMENT THE SENTINEL STUDY (P&S Industry Clinical Trial)

Sep 3 2014 - Sep 3 2019

INTERVENTIONAL CARDIOLOGY FELLOWSHIP (Private)

Jul 1 2018 - Jun 30 2019

INTERVENTIONAL CARDIOLOGY FELLOWSHIP (Private)

Jul 1 2018 - Jun 30 2019

INTERVENTIONAL CARDIOLOGY STRUCTURAL HEART FELLOWSHIP PROGRAM 2018-19 (Private)

Jul 1 2018 - Jun 30 2019

SURGICAL REPLACEMENT AND TRANSCATHETER AORTIC VALVE IMPLANTATION (P&S Industry Clinical Trial)

Sep 26 2013 - Sep 26 2018

(ABBOTT) INTERVENTIONAL CARDIOLOGY FELLOW FUNDING (Private)

Jul 1 2017 - Jun 30 2018

EDWARDS LIFESCIENCES FELLOWSHIP GRANT (Private)

Jul 1 2017 - Jun 30 2018

STRUCTURAL HEART FELLOWSHIP (Private)

Jul 1 2017 - Jun 30 2018

CEREBRAL HEMODYNAMICS AND NEUROCOGNITION IN SEVERE AORTIC VALVE DISEASE (Federal Gov)

Aug 1 2016 - May 31 2018

TRANSCATHETERAORTIC VALVE IMPLANTATION IN PATIENTS WITH LOW-FLOW, LOW-GRADIENT AORTIC STENOSIS (TOPAS TAVI) - A PROSPECTIVE MULTICENTER REGISTRY (Private)

Nov 20 2013 - Mar 1 2018

COLUMBIA GLOBAL VALVULAR HEART DISEASE PROGRAM: A MIXED METHODS APPROACH TO REDUCE THE BURDEN OF RHEUMATIC HEART DISEASE IN PREGNANT WOMEN IN INDIA (Private)

Jan 1 2017 - Dec 31 2017

STRUCTURAL HEART FELLOWSHIP (Private)

Jul 1 2016 - Jun 30 2017

EDWARDS LIFESCIENCES FELLOWSHIP GRANT (Private)

Jul 1 2016 - Jun 30 2017

STRUCTURAL HEART FELLOWSHIP (Private)

Jul 1 2016 - Jun 30 2017

EDWARDS LIFESCIENCES FELLOWSHIP GRANT (Private)

Jul 1 2016 - Jun 30 2017

(ABBOTT) INTERVENTIONAL CARDIOLOGY FELLOW FUNDING (Private)

Jul 1 2016 - Jun 30 2017

(ABBOTT) INTERVENTIONAL CARDIOLOGY FELLOW FUNDING (Private)

Jul 1 2016 - Jun 30 2017

DORIS DUKE CHARITABLE FOUNDATION (Private)

Jul 1 2014 - Apr 14 2017

THE COLUMBIA/NYP PREVIEW OF TCT 2016: A CASE-BASED INTERVENTIONAL WORKSHOP FOR PRACTITIONERS (Private)

Sep 16 2016 - Sep 17 2016

THE COLUMBIA/NYP PREVIEW OF TCT 2016: A CASE-BASED INTERVENTIONAL WORKSHOP FOR PRACTITIONERS (Private)

Sep 16 2016 - Sep 17 2016

THE COLUMBIA/NYP PREVIEW OF TCT 2016: A CASE-BASED INTERVENTIONAL WORKSHOP FOR PRACTITIONERS (Private)

Sep 16 2016 - Sep 17 2016

THE COLUMBIA/NYP PREVIEW OF TCT 2016: A CASE-BASED INTERVENTIONAL WORKSHOP FOR PRACTITIONERS (Private)

Sep 16 2016 - Sep 17 2016

THE COLUMBIA/NYP PREVIEW OF TCT 2016: A CASE-BASED INTERVENTIONAL WORKSHOP FOR PRACTITIONERS (Private)

Sep 16 2016 - Sep 17 2016

STRUCTURAL HEART FELLOWSHIP GRANT (Private)

Jul 1 2015 - Jun 30 2016

EDUCATION AND TRAINING OF INTERVENTIONAL CARDIOLOGY AND VASCULAR MEDICINE FELLOWS (Private)

Jul 1 2015 - Jun 30 2016

PROBABILISTIC MODELING OF STENO TIC AORTIC VALVE INTERVENTION (Federal Gov)

Jun 1 2014 - May 31 2016

PARTNER II (P&S Industry Clinical Trial)

Apr 20 2011 - Apr 20 2016

ABBOTT FUND CARDIOVASCULAR TRAINING FELLOWSHIP (Private)

Jul 1 2014 - Jun 30 2015

DEPRESSION,BIOBEHAVIORAL MECHANISMS, & CHD/MORTALITY OUTCOMES (Federal Gov)

Sep 22 2008 - Nov 30 2014

PROBABILISTIC MODELING OF STENOTIC AORTIC VALVE INTERVENTION (Federal Gov)

Aug 20 2011 - Jun 30 2013

USE OF C-ARM COMPUTED TOMOGRAPHY (CBCT) FOR EVALUATION OF TH E AORTIC ANNULUS AND ASCENDING AORTIC IN PATIENTS CONSIDERED (Private)

May 5 2011 - May 4 2012